Our Core Spirits

Cutting Edge Technology

We are committed to pioneering cutting-edge pharmaceutical technology, driving industry success and growth through continuous improvement and constant development. Our state-of-the-art facility features Taiwan's first automated aseptic filling system.

Agility

A tailored service approach for Drug Innovation, specializing in flexible, customized, agile, and efficient Total CDMO solutions. We adapt swiftly to meet each unique drug development challenge.

SWAT Team

Our seasoned experts unite as one team, ensuring excellence in every drug innovation project we undertake. With extensive industry experience, we are dedicated to ensuring the success of drug innovation clients through unparalleled teamwork and high-level engagement.

Energetic

We take pride in Amaran, actively engaging and contributing our professional expertise to the company. With a sense of mission for our roles, we wholeheartedly dedicate ourselves to the growth of Amaran.

Our Core Value

Our elite team ensures efficient project execution,
transforming ideas into life-changing drugs.

Brand Story

Founded in 2010, Amaran has established itself as a leader in the biopharmaceutical industry, offering comprehensive solutions spanning process development and optimization, analytical services, and regulatory consulting. As a Contract Development and Manufacturing Organization (CDMO) specializing in high-value biopharmaceutical and clinical production, Amaran plays a pivotal role in driving drug innovation with its cutting-edge technology and expertise. Our elite team of seasoned professionals operates with SWAT-like efficiency, continuously advancing through new manufacturing processes and state-of-the-art equipment. By seamlessly collaborating with partners and leveraging our streamlined expertise, we contribute significantly to human health and drive industry development, always staying at the forefront of biopharmaceutical advancements.

Leading drug innovation and transforming ideas into life-changing drugs.

Our Vision

Through high-tech innovation we aim to be a leader in drug manufacturing by providing comprehensive and customized state-of-the-art CDMO service.

Our Mission

Key Milestones

2024

  • PIC/S GMP 2024 certificate granted by TFDA in September.
  • Green Building Label of Building C granted by Ministry of the Interior in July.

2021

  • PIC/S GMP 2021 certificate granted by TFDA in November.

2019

  • PIC/S GMP 2019 certificate granted by TFDA in May. Recertification occurs every 2-3 years.

2017

  • PIC/S GMP certification granted in June.
  • Established and optimized critical processing parameters in the manufacture of 1st & 2nd cGMP products.

2016

  • Amaran Biotech delivers the 2nd cGMP product in June.

2015

  • Amaran Biotech moves into new facility in March.
  • Amaran Biotech receives pharmacist manufacturing license on July 17.
  • First successful cGMP production completed on October 5.

2014

  • Building A construction completed & Amaran Biotech obtains the occupation permit in October.

2013

  • Dr. Tessie Che appointed as Chairperson (February) & General Manager (November).
  • Groundbreaking ceremony at Hsinchu Biomedical Science Park on July 29.
  • Beam-raising ceremony held at Hsinchu Biomedical Science Park on December 2.
  • Collaboration agreement with Stellar Biotechnologies, Inc.(USA) signed on December 12, to develop cGMP grade Keyhole Limpet Hemocyanin as sustainable source for the long-term manufacture of OBI-822.

2010

  • Amaran Biotechnology Inc. is founded by Dr. Michael Chang and Huei Hong Investment Co., Ltd. on April 28.

Certifications & Awards

Asia-Pacific Biopharma Excellence Awards 2025

Taiwan Biopharma Excellence Award 2025

PIC/S GMP

D&B D-U-N-S®Registered